Targeted Plasmalogen Supplementation: Effects on Blood Plasmalogens, Oxidative Stress Biomarkers, Cognition, and Mobility in Cognitively Impaired Persons

2021, The Top 5 Most Feared Health Conditions in 2021

Beeri, 2021, Sarcopenia Is Associated with Incident Alzheimer's Dementia, M Ild Cognitive Impairment, and Cognitive Decline, J. Am. Geriatr. Soc., 69, 1826, 10.1111/jgs.17206

Dorninger, 2017, From Peroxisomal Disorders to Common Neurodegenerative Diseases - the Role of Ether Phospholipids in the Nervous System, FEBS Lett., 591, 2761, 10.1002/1873-3468.12788

Dorninger, 2017, Reduced Muscle Strength in Ether Lipid-Deficient Mice Is Accompanied by Altered Development and Function of the Neuromuscular Junction, J. Neurochem., 143, 569, 10.1111/jnc.14082

Farooqui, 2000, Glycerophospholipids in Brain: Their Metabolism, Incorporation into Membranes, Functions, and Involvement in Neurological Disorders, Chem. Phys. lipids, 106, 1, 10.1016/s0009-3084(00)00128-6

Fujino, 2018, Effects of Plasmalogen on Patients with Mild Cognitive Impairment: A Randomized, Placebo-Controlled Trial in Japan, J. Alzheimers Dis. Park., 8, 10.4172/2161-0460.1000419

Fujino, 2017, Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial, EBioMedicine, 17, 199, 10.1016/j.ebiom.2017.02.012

Galvin, 2015, The Quick Dementia Rating System (Qdrs): A Rapid Dementia Staging Tool, Alzheimer's & Dement. Diagn. Assess. & Dis. Monit., 1, 249, 10.1016/j.dadm.2015.03.003

Ginsberg, 1998, Membrane Instability, Plasmalogen Content, and Alzheimer's Disease, J. Neurochem., 70, 2533, 10.1046/j.1471-4159.1998.70062533.x

Ginsberg, 1995, Disease and Anatomic Specificity of Ethanolamine Plasmalogen Deficiency in Alzheimer's Disease Brain, Brain Res., 698, 223, 10.1016/0006-8993(95)00931-f

Glaser, 1994, Plasmenylethanolamine Facilitates Rapid Membrane Fusion: a Stopped-Flow Kinetic Investigation Correlating the Propensity of a Major Plasma Membrane Constituent to Adopt an HII Phase with its Ability to Promote Membrane Fusion, Biochemistry, 33, 5805, 10.1021/bi00185a019

Glaser, 1995, Rapid Plasmenylethanolamine-Selective Fusion of Membrane Bilayers Catalyzed by an Isoform of Glyceraldehyde-3-Phosphate Dehydrogenase: Discrimination between Glycolytic and Fusogenic Roles of Individual Isoforms, Biochemistry, 34, 12193, 10.1021/bi00038a013

Goodenowe, 2019, Relation of Serum Plasmalogens and APOE Genotype to Cognition and Dementia in Older Persons in a Cross-Sectional Study, Brain Sci., 9, 10.3390/brainsci9040092

Goodenowe, 2007, Peripheral Ethanolamine Plasmalogen Deficiency: a Logical Causative Factor in Alzheimer's Disease and Dementia, J. lipid Res., 48, 2485, 10.1194/jlr.p700023-jlr200

Goodenowe, 2021, Breaking Alzheimer's - A 15 Year Crusade to Expose the Cause and Deliver the Cure

Guan, 1999, Decrease and Structural Modifications of Phosphatidylethanolamine Plasmalogen in the Brain with Alzheimer Disease, J. Neuropathology Exp. Neurology, 58, 740, 10.1097/00005072-199907000-00008

Gutteridge, 1984, Lipid Peroxidation Initiated by Superoxide-dependent Hydroxyl Radicals Using Complexed Iron and Hydrogen Peroxide, FEBS Lett., 172, 245, 10.1016/0014-5793(84)81134-5

Han, 2001, Plasmalogen Deficiency in Early Alzheimer's Disease Subjects and in Animal Models: Molecular Characterization Using Electrospray Ionization Mass Spectrometry, J. Neurochem., 77, 1168, 10.1046/j.1471-4159.2001.00332.x

Han, 2005, Lipid Alterations in the Earliest Clinically Recognizable Stage of Alzheimers Disease: Implication of the Role of Lipids in the Pathogenesis of Alzheimers Disease, Car, 2, 65, 10.2174/1567205052772786

Hossain, 2022, Plasmalogens, the Vinyl Ether-Linked Glycerophospholipids, Enhance Learning and Memory by Regulating Brain-Derived Neurotrophic Factor, Front. Cell. Dev. Biol., 10, 828282, 10.3389/fcell.2022.828282

Kamper, 2009, Global Rating of Change Scales: a Review of Strengths and Weaknesses and Considerations for Design, J. Man. Manip. Ther., 17, 163, 10.1179/jmt.2009.17.3.163

Kassmann, 2007, Axonal Loss and Neuroinflammation Caused by Peroxisome-Deficient Oligodendrocytes, Nat. Genet., 39, 969, 10.1038/ng2070

Kling, 2020, Circulating Ethanolamine Plasmalogen Indices in Alzheimer's Disease: Relation to Diagnosis, Cognition, and CSF Tau, Alzheimer's & Dement., 16, 1234, 10.1002/alz.12110

Kokkaliari, 1992, Serum Catalase as the Protective Agent against Inactivation of Alpha 1-proteinase Inhibitor by Hydrogen Peroxide; Comparison between Normal and Rheumatoid Sera, Biochem. Int., 28, 219

Lim, 2020, Relationships between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease, Jad, 76, 303, 10.3233/jad-191304

Mankidy, 2010, Membrane Plasmalogen Composition and Cellular Cholesterol Regulation: a Structure Activity Study, Lipids Health Dis., 9, 62, 10.1186/1476-511x-9-62

McAllister, 2020, Modified 30-Second Sit-To-Stand Test: Reliability and Validity in Older Adults Unable to Complete Traditional Sit-To-Stand Testing, J. Geriatr. Phys. Ther., 43, 153, 10.1519/jpt.0000000000000227

Messias, 2018, Plasmalogen Lipids: Functional Mechanism and Their Involvement in Gastrointestinal Cancer, Lipids Health Dis., 17, 41, 10.1186/s12944-018-0685-9

Munn, 2003, Deficiency in Ethanolamine Plasmalogen Leads to Altered Cholesterol Transport, J. lipid Res., 44, 182, 10.1194/jlr.m200363-jlr200

Pacifico, 2020, Prevalence of Sarcopenia as a Comorbid Disease: A Systematic Review and Meta-Analysis, Exp. Gerontol., 131, 110801, 10.1016/j.exger.2019.110801

Rouser, 1968, Curvilinear Regression Course of Human Brain Lipid Composition Changes with Age, Lipids, 3, 284, 10.1007/bf02531202

Senanayake, 2019, Plasmalogen Deficiency and Neuropathology in Alzheimer's Disease: Causation or Coincidence?, Alzheimer's & Dementia Transl. Res. & Clin. Interventions, 5, 524, 10.1016/j.trci.2019.08.003

Sindelar, 1999, The Protective Role of Plasmalogens in Iron-Induced Lipid Peroxidation, Free Radic. Biol. Med., 26, 318, 10.1016/s0891-5849(98)00221-4

Stables, 2011, Old and New Generation Lipid Mediators in Acute Inflammation and Resolution, Prog. Lipid Res., 50, 35, 10.1016/j.plipres.2010.07.005

Stadelmann-Ingrand, 2001, Plasmalogen Degradation by Oxidative Stress: Production and Disappearance of Specific Fatty Aldehydes and Fatty α-hydroxyaldehydes, Free Radic. Biol. Med., 31, 1263, 10.1016/s0891-5849(01)00720-1

Sullivan-Gunn, 2013, Elevated Hydrogen Peroxide and Decreased Catalase and Glutathione Peroxidase Protection Are Associated with Aging Sarcopenia, BMC Geriatr., 13, 104, 10.1186/1471-2318-13-104

Wood, 2011, Plasmalogen Deficit: A New and Testable Hypothesis for the Etiology of Alzheimer’s Disease, Alzheimer's Disease Pathogenesis-Core Concepts, Shifting Paradigms and Therapeutic Targets

Wood, 2011, Cellular Diamine Levels in Cancer Chemoprevention: Modulation by Ibuprofen and Membrane Plasmalogens, Lipids Health Dis., 10, 214, 10.1186/1476-511x-10-214

Wood, 2010, Circulating Plasmalogen Levels and Alzheimer Disease Assessment Scale-Cognitive Scores in Alzheimer Patients, jpn, 35, 59, 10.1503/jpn.090059

Wood, 2011, Oral Bioavailability of the Ether Lipid Plasmalogen Precursor, PPI-1011, in the Rabbit: a New Therapeutic Strategy for Alzheimer's Disease, Lipids Health Dis., 10, 227, 10.1186/1476-511x-10-227

Wood, 2011, Targeted Metabolomic Analyses of Cellular Models of Pelizaeus-Merzbacher Disease Reveal Plasmalogen and Myo-Inositol Solute Carrier Dysfunction, Lipids Health Dis., 10, 102, 10.1186/1476-511x-10-102

Yoo, 1999, The Activation of the Rat Copper/zinc Superoxide Dismutase Gene by Hydrogen Peroxide through the Hydrogen Peroxide-Responsive Element and by Paraquat and Heat Shock through the Same Heat Shock Element, J. Biol. Chem., 274, 23887, 10.1074/jbc.274.34.23887

Zoeller, 1999, Plasmalogens as Endogenous Antioxidants: Somatic Cell Mutants Reveal the Importance of the Vinyl Ether, Biochem. J., 769, 10.1042/bj3380769